Hixon Zuercher LLC Has $602,000 Stake in Procter & Gamble Company (The) $PG

Hixon Zuercher LLC reduced its position in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 23.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,780 shares of the company’s stock after selling 1,175 shares during the period. Hixon Zuercher LLC’s holdings in Procter & Gamble were worth $602,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in PG. MOKAN Wealth Management Inc. increased its holdings in Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock worth $2,442,000 after buying an additional 1,846 shares during the last quarter. Benjamin Edwards Inc. increased its stake in shares of Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after purchasing an additional 199,258 shares during the period. Capital Investment Advisory Services LLC lifted its holdings in shares of Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock worth $6,426,000 after buying an additional 4,562 shares in the last quarter. World Investment Advisors raised its stake in Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after purchasing an additional 2,886 shares in the last quarter. Finally, Caliber Wealth Management LLC KS boosted its stake in shares of Procter & Gamble by 36.2% in the second quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock valued at $2,836,000 after buying an additional 4,730 shares during the period. Institutional investors own 65.77% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. BNP Paribas Exane cut their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Barclays reduced their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Raymond James Financial lowered their target price on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. UBS Group dropped their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, Bank of America decreased their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $171.68.

Read Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Up 0.3%

PG stock opened at $152.62 on Friday. The stock has a market cap of $357.21 billion, a P/E ratio of 22.28, a P/E/G ratio of 4.05 and a beta of 0.36. The stock’s fifty day simple moving average is $154.66 and its two-hundred day simple moving average is $158.41. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 1-year low of $146.96 and a 1-year high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. During the same period last year, the business posted $1.93 earnings per share. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is currently 64.98%.

Insider Activity

In related news, CFO Andre Schulten sold 11,638 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. This represents a 18.11% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jon R. Moeller sold 40,119 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares in the company, valued at $50,228,106.25. This represents a 11.16% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock valued at $23,421,279. Insiders own 0.20% of the company’s stock.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.